DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Boyle MP, Bell SC, Konstan MW et al.
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial.
Lancet Respir Med 2014;
2: 527-538
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.